USPTO serial 79266874
Serial No. 79266874
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Sep 1, 2020
- Examiner
- MESSICK, TABITHA LEE
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.
Need help with Serial No. 79266874?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $399*
Plus Government fees of $425
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
YANGTZE RIVER PHARMACEUTICAL(GROUP) CO.,LTD.
CN
Other trademarks owned by YANGTZE RIVER PHARMACEUTICAL(GROUP) CO.,LTD.
YANGTZE RIVER PHARMACEUTICAL(GROUP) CO.,LTD.
CN
Other trademarks owned by YANGTZE RIVER PHARMACEUTICAL(GROUP) CO.,LTD.
YANGTZE RIVER PHARMACEUTICAL(GROUP) CO.,LTD.
CN
Other trademarks owned by YANGTZE RIVER PHARMACEUTICAL(GROUP) CO.,LTD.
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Prakash NAMA
121 Moore St.Princeton, NJ 08540UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Chemico-pharmaceutical preparations, namely, anti-infectives, pain relief medication, cardiovascular pharmaceuticals, digestives for pharmaceutical purposes, Chinese traditional medicinal herbs, tumor suppressing agents, X-ray contrast agents, pharmaceutical preparations acting on the central nervous system; collyrium; analgesics; medicines for human purposes, namely, anti-infectives, pain relief medication, cardiovascular pharmaceuticals, digestives for pharmaceutical purposes, Chinese traditional medicinal herbs, tumor suppressing agents, X-ray contrast agents, pharmaceutical preparations acting on the central nervous system; medicinal drinks; ointment for pharmaceutical use, namely, medicated ointments for treating dermatological conditions; Chinese medicine nostrum namely, medicinal herbs; adhesive patches for medical use, namely medical plasters; biochemical pharmaceutical preparations, namely, anti-infectives, pain relief medication, cardiovascular pharmaceuticals, digestives for pharmaceutical purposes, Chinese traditional medicinal herbs, tumor suppressing agents, X-ray contrast agents, pharmaceutical preparations acting on the central nervous system; blood for medical use; blood plasma; blood substitutes for human, veterinary use; medicines in form of glue balls, namely anti-infectives, pain relief medication, cardiovascular pharmaceuticals, digestives for pharmaceutical purposes, Chinese traditional medicinal herbs, tumor suppressing agents, X-ray contrast agents, pharmaceutical preparations acting on the central nervous system; medical drinks in the nature of flavored tonic liquors; dietetic foods adapted for medical purposes; depuratives for the body; animal feed additives for medical purpose for use as nutritional supplements; parasiticides; wadding for medical purposes; pharmaceutical preparations to facilitate teething | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by YANGTZE RIVER PHARMACEUTICAL(GROUP) CO.,LTD.
- Other trademarks owned by YANGTZE RIVER PHARMACEUTICAL(GROUP) CO.,LTD.
- Other trademarks owned by YANGTZE RIVER PHARMACEUTICAL(GROUP) CO.,LTD.
- Other trademarks in Class 005
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Nov 20, 2025 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Sep 1, 2025 | REM3 | COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED | — |
| Feb 13, 2021 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Dec 22, 2020 | XXSS | GENERIC MADRID TRANSACTION SENT TO IB | — |
| Dec 21, 2020 | XXCR | GENERIC MADRID TRANSACTION CREATED | — |
| Dec 1, 2020 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Sep 1, 2020 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Jun 16, 2020 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Jun 16, 2020 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jun 12, 2020 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| May 27, 2020 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| May 27, 2020 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| May 27, 2020 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| May 12, 2020 | ALIE | ASSIGNED TO LIE | — |
| May 8, 2020 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| May 5, 2020 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| May 4, 2020 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| May 4, 2020 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Dec 20, 2019 | RFNT | REFUSAL PROCESSED BY IB | — |
| Dec 5, 2019 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Dec 5, 2019 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Nov 14, 2019 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Nov 13, 2019 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Nov 4, 2019 | DOCK | ASSIGNED TO EXAMINER | — |
| Sep 20, 2019 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Sep 16, 2019 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Sep 14, 2019 | LIMI | LIMITATION FROM ORIGINAL APPLICATION ENTERED | — |
| Sep 5, 2019 | SDRC | SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB | — |